BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test Jun 23, 2026 08:30AM
BioMark secures US patent for urine-based lung cancer screening test Jun 9, 2026 08:32AM
BioMark Secures Broad U.S. Patent for Urine-Based Lung Cancer Screening, Expanding Differentiated Liquid Biopsy Testing Platform Jun 9, 2026 08:30AM
BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum Apr 14, 2026 08:30AM
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology Jan 15, 2026 08:30AM


Dec 31, 2025 08:30AM BioMark: 2025 Achievements & 2026 Vision
Dec 30, 2025 08:32AM BioMark Diagnostics appoints James Lavender to board of directors
Dec 30, 2025 08:30AM BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors
Dec 23, 2025 08:30AM BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
Dec 1, 2025 08:30AM BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala
Nov 12, 2025 08:30AM BioMark Aligns with National Strategy to Slash Lung Cancer Mortality with Next-Gen Liquid Biopsy
Oct 7, 2025 08:30AM BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial
Sep 29, 2025 08:30AM BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy
Aug 12, 2025 08:30AM BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare Partnership
Aug 5, 2025 08:30AM BioMark Diagnostics Announces Expansion of Its Specialty Laboratory Services in Quebec to Accommodate Increased Demand from International Partnerships
Jul 30, 2025 08:30AM BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 - 2026
May 20, 2025 08:30AM BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology
May 12, 2025 08:30AM BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test
May 8, 2025 08:30AM BioMark Diagnostics Announces Uplisting to OTCQB Venture Market